Bottom line
How much do PPH and FHLC overlap?
42% of their top holdings overlap by weight. 8 securities appear in both funds' top 25, making up 55.5% of PPH's assets and 39.7% of FHLC's. They share a meaningful core but differ in the rest of the portfolio.
FHLC holds far more positions (337 vs 26), so it is broader beyond the top names.
Updated Nov 22, 2026
Overlap at a glance
Holdings PPH and FHLC have in common
| Holding | % of PPH | % of FHLC | Overlap |
|---|---|---|---|
| Eli Lilly & Co | 20.23% | 13.35% | 13.35% |
| Merck & Co Inc | 9.85% | 4.66% | 4.66% |
| AbbVie Inc | 4.57% | 6.42% | 4.57% |
| Pfizer Inc | 4.51% | 2.06% | 2.06% |
| Bristol-Myers Squibb Co | 4.47% | 1.93% | 1.93% |
| Johnson & Johnson | 4.35% | 8.93% | 4.35% |
| McKesson Corp | 4.12% | 1.52% | 1.52% |
| Cencora Inc | 3.36% | 0.83% | 0.83% |
Source: SEC Form N-PORT (periods Jun 30, 2026 / Jul 31, 2026)
Free weekly newsletter
The Fund Letter
Get fee cuts and hikes, fund closures and mergers, and one plain-English idea to make your portfolio cheaper — every week.
Free. Unsubscribe anytime. We never sell your email.
What each fund holds that the other doesn't
Top-25 holdings that appear in only one of the two funds' top 25.
Only in PPH
- Novartis AG — 10.63%
- Novo Nordisk A/S — 5.37%
- Gsk Plc — 4.42%
- AstraZeneca PLC — 4.33%
- Sanofi SA — 4.00%
- Haleon PLC — 3.09%
- Teva Pharmaceutical Industries Ltd — 3.06%
- Takeda Pharmaceutical Co Ltd — 2.87%
- Zoetis Inc — 2.10%
- Viatris Inc — 1.10%
- Jazz Pharmaceuticals PLC — 1.08%
- Axsome Therapeutics Inc — 0.77%
- Corcept Therapeutics Inc — 0.50%
- Elanco Animal Health Inc — 0.35%
- State Street Global Advisors — 0.28%
Only in FHLC
- UnitedHealth Group Inc — 5.44%
- Thermo Fisher Scientific Inc — 3.09%
- Amgen Inc — 3.00%
- Abbott Laboratories — 2.66%
- Gilead Sciences Inc — 2.34%
- CVS Health Corp — 1.92%
- Intuitive Surgical Inc — 1.82%
- Danaher Corp — 1.80%
- Vertex Pharmaceuticals Inc — 1.76%
- Stryker Corp — 1.62%
- Medtronic PLC — 1.59%
- Elevance Health Inc — 1.19%
- Regeneron Pharmaceuticals Inc — 1.15%
- Cigna Group/The — 1.06%
- Boston Scientific Corp — 1.00%
Asset mix
| Asset type | PPH | FHLC |
|---|---|---|
| Stocks | 99.5% | 99.7% |
| Cash & short-term funds | 0.3% | 0.2% |
Source: SEC Form N-PORT (periods Jun 30, 2026 / Jul 31, 2026)
Country mix
| Country | PPH | FHLC |
|---|---|---|
| US | 60.8% | 96.5% |
| GB | 11.8% | 0.5% |
| CH | 10.6% | 0.1% |
| DK | 5.4% | — |
| FR | 4.0% | — |
| IL | 3.1% | — |
| JP | 2.9% | — |
| IE | 1.1% | 2.2% |
Source: SEC Form N-PORT (periods Jun 30, 2026 / Jul 31, 2026)
Check another pair
FAQ
How much do PPH and FHLC overlap?
What stocks do PPH and FHLC have in common?
Should I own both PPH and FHLC?
Which holds more stocks, PPH or FHLC?
Overlap is computed from each fund's top 25 holdings in its latest SEC Form N-PORT filing, with weights normalized to the top 25; for each shared security we count the smaller of the two weights. Educational information, not investment advice.